Who owns Spruce Biosciences?

Spruce Biosciences is currently owned by Abingworth, through Abingworth Bioventures VII, since 2020.

When did Abingworth acquire Spruce Biosciences?

Abingworth acquired Spruce Biosciences in 2020 (active for 6 years).

Home/Companies/Biotech/Spruce Biosciences

Biotech·

US·Active·6yr hold

Spruce Biosciences is a biotech company, headquartered in US.

Entry

2020

Hold

6yr

Status

Active

Est. EV

–

Investor

HQUS

SectorBiotech

StatusActive

US biopharmaceutical company developing therapies for rare endocrine disorders; Abingworth co-led its 2020 Series B financing.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Already a member? Sign in

Comparable biotech deals from other GPs.

Last updated May 2026 · Sourced from public filings